Tag - japan-medicine

 
 

JAPAN MEDICINE

JAPAN
Jul 29, 2022
Japan to let prefectures declare new anti-COVID measures but won't curb social activities
Governors will now be able to declare that their prefectures are in need of measures to counter the BA.5 subvariant when their health care systems are severely strained.
JAPAN / Science & Health / EXPLAINER
Jul 28, 2022
Everything you need to know about BA.5, the dominant strain spreading across Japan
Amid a seventh wave of infections, daily case numbers have been reaching unprecedented highs, with the nation logging 969,000 cases over the seven-day span to Sunday.
JAPAN / Science & Health
Jul 20, 2022
Health ministry panel delays decision on emergency approval for Shionogi’s COVID pill
The delay is a blow to one of Japan's largest drugmakers and also raises questions about the process for drugs to gain fast-track approvals in times of emergency.
JAPAN / Science & Health
Jun 23, 2022
Japanese panel postpones verdict on Shionogi’s COVID pill until July
The panel “could not reach a conclusion,” as its members were divided over several points including the efficacy of the drug, according to a health ministry official.
JAPAN
Jun 21, 2022
As Japan's verdict on Shionogi's COVID pill nears, questions persist over efficacy
There have been calls for Japan to acquire more weapons against COVID-19, especially domestically produced ones, but medical experts are unsure of the drug's merits.
Japan Times
JAPAN / Science & Health / FOCUS
Jun 18, 2022
How Japan achieved one of the world’s lowest COVID-19 death rates
Health experts point to continued mask wearing, extensive vaccination and an already healthy population as the core factors behind its success.
Japan Times
JAPAN / Science & Health
Apr 24, 2022
Japan's Shionogi says COVID-19 pill shows rapid clearance of virus
The pill, S-217622, 'demonstrated rapid clearance of the infectious SARS-CoV-2 virus,' the Japanese drugmaker Shionogi says.
Japan Times
JAPAN
Mar 11, 2022
Fujifilm to halt enrollment in Avigan trial for COVID-19
The emergence of the omicron variant, which usually causes milder infections, made it tough to determine the drug's effectiveness in preventing severe symptoms, the company said.
JAPAN / Science & Health
Feb 25, 2022
Shionogi seeks approval for Japan’s first domestic COVID pill
Kishida has signaled that the central government will expedite the review process to pave the way for a swift approval if the drug's efficacy and safety are confirmed.
Japan Times
JAPAN / Science & Health
Feb 10, 2022
Japanese health ministry approves Pfizer's COVID-19 oral treatment drug
The drug, paxlovid, is to be used for the treatment of mild-to-moderate COVID-19 in people 12 and older and who are at high risk of developing severe symptoms.
Japan Times
COMMENTARY / Japan
Jan 12, 2022
SOFA exempts U.S. forces from Japan’s laws, as it does its COVID safety measures
Beyond the issues associated with the U.S. military's lax COVID-19 containment measures, SOFA has a long history of incidents.
JAPAN / FOCUS
Dec 21, 2021
Ivermectin for COVID? Unproven treatment stokes concern in Japan
Although the treatment has received some support from Japan's medical establishment and studies are ongoing, ivermectin is not approved as a COVID-19 remedy in the country.
Japan Times
JAPAN / Science & Health
Dec 10, 2021
Japan researchers use ostrich cells to make glowing COVID-19 detection masks
The discovery could help advance low-cost, at-home testing, and may potentially help those suffering from allergies and other ailments.
COMMENTARY / World
Nov 24, 2021
Mass COVID-19 testing: Does it save lives?
Would Japan have seen far greater fatalities if it opted for mass COVID-19 testing like other countries rather than just targeting vulnerable group as it did?
JAPAN
Nov 13, 2021
COVID cases in Tokyo hit 471,000 as of March — quadruple official tally — study says
Researchers say asymptomatic or mild cases likely behind dramatic undercount in number of coronavirus infections.
JAPAN / Explainer
Oct 20, 2021
Oral drug molnupiravir seen as 'trump card' in Japan's battle against COVID-19
The treatment developed by Merck could receive fast-track approval by the end of the year, and other oral drugs to fight the coronavirus are not far behind.

Longform

Sumadori Bar on Shibuya Ward's main Center Gai street targets young customers who prefer low-alcohol drinks or abstain altogether.
Rethinking that second drink: Japan’s Gen Z gets ‘sober curious’